{"id":"NCT00533507","sponsor":"GlaxoSmithKline","briefTitle":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age","officialTitle":"Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Infanrix Hexa and Rotarix","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09-18","primaryCompletion":"2008-06-01","completion":"2008-06-06","firstPosted":"2007-09-21","resultsPosted":"2009-07-24","lastUpdate":"2018-06-08"},"enrollment":230,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Rotavirus"],"interventions":[{"type":"BIOLOGICAL","name":"Synflorix","otherNames":["Pneumococcal conjugate vaccine GSK1024850A"]},{"type":"BIOLOGICAL","name":"Infanrix hexa","otherNames":["DTPa-HBV-IPV/Hib"]},{"type":"BIOLOGICAL","name":"Rotarix","otherNames":["HRV vaccine"]}],"arms":[{"label":"Synflorix group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the immunogenicity in terms of antibody response and the safety/reactogenicity in terms of solicited and unsolicited symptoms and serious adverse events following primary vaccination of Taiwanese infants with pneumococcal conjugate vaccine GSK 1024850A co-administered with a diphtheria, tetanus, acellular pertussis (DTPa)-combined vaccine and rotavirus vaccine in children during the first 6 months of life.","primaryOutcome":{"measure":"Concentration of Anti-Protein D Antibodies","timeFrame":"One month after the third dose","effectByArm":[{"arm":"Synflorix Group","deltaMin":2277.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Weeks","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":15},"locations":{"siteCount":3,"countries":["Taiwan"]},"refs":{"pmids":["23021506"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":15},"commonTop":["Irritability","Drowsiness","Loss of appetite","Fever","Pain"]}}